{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:06:31Z","timestamp":1788303991094,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"CONACYT\u00b4s grants from Basic Science Sectorial Fund SEP-CONACYT","award":["CB-2014-01-222618"],"award-info":[{"award-number":["CB-2014-01-222618"]}]},{"name":"National Laboratory Special Fund CONACYT","award":["LN-293405"],"award-info":[{"award-number":["LN-293405"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The International Journal of Biochemistry & Cell Biology"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.biocel.2018.09.007","type":"journal-article","created":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T13:17:14Z","timestamp":1537190234000},"page":"133-137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["Human \u03b2-defensin 1 update: Potential clinical applications of the restless warrior"],"prefix":"10.1016","volume":"104","author":[{"given":"\u00c1ngel H.","family":"\u00c1lvarez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mois\u00e9s","family":"Mart\u00ednez Vel\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto","family":"Prado Montes de Oca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.biocel.2018.09.007_bib0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021898","article-title":"Increased expression of beta-defensin 1 (DEFB1) in chronic obstructive pulmonary disease","volume":"6","author":"Andresen","year":"2011","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.biocel.2018.09.007_bib0010","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jdermsci.2005.03.014","article-title":"Synergistic effect of antibacterial agents human beta-defensins, cathelicidin LL-37 and lysozyme against Staphylococcus aureus and Escherichia coli","volume":"40","author":"Chen","year":"2005","journal-title":"J. Dermatol. Sci."},{"issue":"1","key":"10.1016\/j.biocel.2018.09.007_bib0015","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00726-010-0493-7","article-title":"Expression systems of human beta-defensins: vectors, purification and biological activities","volume":"40","author":"Corrales-Garcia","year":"2011","journal-title":"Amino Acids"},{"key":"10.1016\/j.biocel.2018.09.007_bib0020","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/714580","article-title":"Ascorbic acid, ultraviolet C rays, and glucose but not hyperthermia are elicitors of human beta-defensin 1 mRNA in normal keratinocytes","volume":"2015","author":"Cruz Diaz","year":"2015","journal-title":"Biomed Res. Int."},{"issue":"249","key":"10.1016\/j.biocel.2018.09.007_bib0025","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3009071","article-title":"Deficient human beta-defensin 1 underlies male infertility associated with poor sperm motility and genital tract infection","volume":"6","author":"Diao","year":"2014","journal-title":"Sci. Transl. Med."},{"issue":"8","key":"10.1016\/j.biocel.2018.09.007_bib0030","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1021\/acs.jmedchem.8b00251","article-title":"Human beta-defensin 1 and beta-defensin 3 (mouse ortholog mBD14) function as full endogenous agonists at select melanocortin receptors","volume":"61","author":"Ericson","year":"2018","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.biocel.2018.09.007_bib0035","doi-asserted-by":"crossref","first-page":"220","DOI":"10.2174\/1570162X12666140708102722","article-title":"DEFB1 5\u2019UTR polymorphisms modulate the risk of HIV-1 infection in Mexican women","volume":"12","author":"Estrada-Aguirre","year":"2014","journal-title":"Curr. HIV Res."},{"issue":"Pt A","key":"10.1016\/j.biocel.2018.09.007_bib0040","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.compbiolchem.2015.09.002","article-title":"Predicting functional regulatory SNPs in the human antimicrobial peptide genes DEFB1 and CAMP in tuberculosis and HIV\/AIDS","volume":"59","author":"Flores Saiffe Farias","year":"2015","journal-title":"Comput. Biol. Chem."},{"issue":"12","key":"10.1016\/j.biocel.2018.09.007_bib0045","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/apm.12749","article-title":"A role of human beta defensin-1 in predicting prostatic adenocarcinoma in cases of false-negative biopsy","volume":"125","author":"Hong","year":"2017","journal-title":"APMIS"},{"key":"10.1016\/j.biocel.2018.09.007_bib0050","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.12659\/MSM.893453","article-title":"Association between genetic polymorphisms in DEFB1 and susceptibility to digestive diseases","volume":"21","author":"Huang","year":"2015","journal-title":"Med. Sci. Monit."},{"issue":"6","key":"10.1016\/j.biocel.2018.09.007_bib0055","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/mi.2013.17","article-title":"Cell-mediated reduction of human beta-defensin 1: a major role for mucosal thioredoxin","volume":"6","author":"Jaeger","year":"2013","journal-title":"Mucosal Immunol."},{"issue":"11","key":"10.1016\/j.biocel.2018.09.007_bib0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050000","article-title":"Histone deacetylase (HDAC) 1 controls the expression of beta defensin 1 in human lung epithelial cells","volume":"7","author":"Kallsen","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.biocel.2018.09.007_bib0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062717","article-title":"High concentrations of L-ascorbic acid specifically inhibit the growth of human leukemic cells via downregulation of HIF-1alpha transcription","volume":"8","author":"Kawada","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.biocel.2018.09.007_bib0070","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/mi.2013.6","article-title":"Fundamental role for HIF-1alpha in constitutive expression of human beta defensin-1","volume":"6","author":"Kelly","year":"2013","journal-title":"Mucosal Immunol."},{"issue":"8","key":"10.1016\/j.biocel.2018.09.007_bib0075","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.freeradbiomed.2012.07.079","article-title":"Enhanced antitumor activity of vitamin C via p53 in cancer cells","volume":"53","author":"Kim","year":"2012","journal-title":"Free Radic. Biol. Med."},{"issue":"11","key":"10.1016\/j.biocel.2018.09.007_bib0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002355","article-title":"Novel anti-bacterial activities of beta-defensin 1 in human platelets: suppression of pathogen growth and signaling of neutrophil extracellular trap formation","volume":"7","author":"Kraemer","year":"2011","journal-title":"PLoS Pathog."},{"issue":"14","key":"10.1016\/j.biocel.2018.09.007_bib0085","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1158\/1078-0432.CCR-15-0288","article-title":"Targeting PI3K\/mTOR signaling displays potent antitumor efficacy against nonfunctioning pituitary adenomas","volume":"21","author":"Lee","year":"2015","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.biocel.2018.09.007_bib0090","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s12602-017-9286-6","article-title":"Distinct histone modifications modulate DEFB1 expression in human vaginal keratinocytes in response to Lactobacillus spp","volume":"9","author":"Lee","year":"2017","journal-title":"Probiotics Antimicrob. Proteins"},{"issue":"1","key":"10.1016\/j.biocel.2018.09.007_bib0095","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.pep.2012.11.015","article-title":"Cloning, expression and characterization of antimicrobial porcine beta defensin 1 in Escherichia coli","volume":"88","author":"Li","year":"2013","journal-title":"Protein Expr. Purif."},{"issue":"1","key":"10.1016\/j.biocel.2018.09.007_bib0100","doi-asserted-by":"crossref","first-page":"13404","DOI":"10.1038\/s41598-017-13332-0","article-title":"Beta-defensin 1 expression in HCV infected liver\/liver cancer: an important role in protecting HCV progression and liver cancer development","volume":"7","author":"Ling","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.biocel.2018.09.007_bib0105","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41398-017-0056-8","article-title":"Beta-defensin 1, aryl hydrocarbon receptor and plasma kynurenine in major depressive disorder: metabolomics-informed genomics","volume":"8","author":"Liu","year":"2018","journal-title":"Transl. Psychiatry"},{"issue":"3","key":"10.1016\/j.biocel.2018.09.007_bib0110","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1167\/iovs.06-0090","article-title":"Melanocortin 1 receptor is expressed by uveal malignant melanoma and can be considered a new target for diagnosis and immunotherapy","volume":"48","author":"Lopez","year":"2007","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.biocel.2018.09.007_bib0115","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/iji.12080","article-title":"Polymorphism in cathelicidin gene (CAMP) that alters Hypoxia-inducible factor (HIF-1alpha::ARNT) binding is not associated with tuberculosis","volume":"41","author":"Lopez Campos","year":"2014","journal-title":"Int. J. Immunogenet."},{"issue":"27","key":"10.1016\/j.biocel.2018.09.007_bib0120","first-page":"9128","article-title":"Relevance of alpha-defensins (HNP1-3) and defensin beta-1 in diabetes","volume":"20","author":"Nemeth","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.biocel.2018.09.007_bib0125","article-title":"Association of human beta-defensin 1 gene polymorphisms with nonsegmental vitiligo","author":"Ochoa-Ramirez","year":"2018","journal-title":"Clin. Exp. Dermatol."},{"issue":"1","key":"10.1016\/j.biocel.2018.09.007_bib0130","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1128\/AAC.03901-14","article-title":"A hybrid cationic peptide composed of human beta-defensin-1 and humanized theta-defensin sequences exhibits salt-resistant antimicrobial activity","volume":"59","author":"Olli","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.biocel.2018.09.007_bib0135","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s11248-014-9847-3","article-title":"Utilization of plant-derived recombinant human beta-defensins (hBD-1 and hBD-2) for averting salmonellosis","volume":"24","author":"Patro","year":"2015","journal-title":"Transgenic Res."},{"issue":"3","key":"10.1016\/j.biocel.2018.09.007_bib0140","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1177\/1753425912460708","article-title":"Antimicrobial Peptide Elicitors: new hope for the post-antibiotic era","volume":"19","author":"Prado Montes de Oca","year":"2013","journal-title":"Innate Immun."},{"key":"10.1016\/j.biocel.2018.09.007_bib0145","series-title":"Leprosy Treatment in, Leprosy: Epidemiology, Treatment Strategies and Current Challenges in Research","article-title":"The potential of antimicrobial peptide inhibitors (APIs) and elicitors (APEs)","author":"Prado Montes de Oca","year":"2014"},{"issue":"6","key":"10.1016\/j.biocel.2018.09.007_bib0150","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.biocel.2010.01.021","article-title":"Human beta-defensin 1: a restless warrior against allergies, infections and cancer","volume":"42","author":"Prado-Montes de Oca","year":"2010","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"3","key":"10.1016\/j.biocel.2018.09.007_bib0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006261","article-title":"Ubiquitously expressed Human Beta defensin 1 (hBD1) forms bacteria-entrapping nets in a redox dependent mode of action","volume":"13","author":"Raschig","year":"2017","journal-title":"PLoS Pathog."},{"issue":"6","key":"10.1016\/j.biocel.2018.09.007_bib0160","article-title":"Modulation of human beta-Defensin-1 production by","volume":"9","author":"Ryan","year":"2017","journal-title":"Viruses. Viruses"},{"issue":"7330","key":"10.1016\/j.biocel.2018.09.007_bib0165","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nature09674","article-title":"Reduction of disulphide bonds unmasks potent antimicrobial activity of human beta-defensin 1","volume":"469","author":"Schroeder","year":"2011","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.biocel.2018.09.007_bib0170","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/pr.2013.23","article-title":"Esophageal human beta-defensin expression in eosinophilic esophagitis","volume":"73","author":"Schroeder","year":"2013","journal-title":"Pediatr. Res."},{"issue":"19","key":"10.1016\/j.biocel.2018.09.007_bib0175","doi-asserted-by":"crossref","first-page":"7239","DOI":"10.1007\/s00253-017-8466-3","article-title":"Activity of human beta defensin-1 and its motif against active and dormant Mycobacterium tuberculosis","volume":"101","author":"Sharma","year":"2017","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"17","key":"10.1016\/j.biocel.2018.09.007_bib0180","doi-asserted-by":"crossref","first-page":"8542","DOI":"10.1158\/0008-5472.CAN-06-0294","article-title":"Human beta-defensin-1, a potential chromosome 8p tumor suppressor: control of transcription and induction of apoptosis in renal cell carcinoma","volume":"66","author":"Sun","year":"2006","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.biocel.2018.09.007_bib0185","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1017\/S0007114516000234","article-title":"Levels of innate immune factors in preterm and term mothers\u2019 breast milk during the 1st month postpartum","volume":"115","author":"Trend","year":"2016","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.biocel.2018.09.007_bib0190","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/1742-2094-10-127","article-title":"Antimicrobial peptide beta-defensin-1 expression is upregulated in Alzheimer\u2019s brain","volume":"10","author":"Williams","year":"2013","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.biocel.2018.09.007_bib0195","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10295-011-0992-x","article-title":"Production of bioactive sheep beta-defensin-1 in Pichia pastoris","volume":"39","author":"Zhao","year":"2012","journal-title":"J. Ind. Microbiol. Biotechnol."},{"issue":"1","key":"10.1016\/j.biocel.2018.09.007_bib0200","doi-asserted-by":"crossref","first-page":"79","DOI":"10.31768\/2312-8852.2018.40(1):79-81","article-title":"Effect of cytostatic agents on expression levels of human beta-defensins-1-4 in A431 and MCF-7 cell lines","volume":"40","author":"Zubenko","year":"2018","journal-title":"Exp. Oncol."}],"container-title":["The International Journal of Biochemistry & Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272518302000?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272518302000?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T07:11:47Z","timestamp":1761203507000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1357272518302000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":40,"alternative-id":["S1357272518302000"],"URL":"https:\/\/doi.org\/10.1016\/j.biocel.2018.09.007","relation":{},"ISSN":["1357-2725"],"issn-type":[{"value":"1357-2725","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human \u03b2-defensin 1 update: Potential clinical applications of the restless warrior","name":"articletitle","label":"Article Title"},{"value":"The International Journal of Biochemistry & Cell Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biocel.2018.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}